Uncategorized

Design Therapeutics’ Friedreich ataxia data; Vincentage’s obesity results from China

Design Therapeutics’ Friedreich ataxia data; Vincentage’s obesity results from China

Published

4 weeks ago

on

Plus, news about Enhertu and Tecentriq.

💪 Design Therapeutics shares Phase 1/2 data in Friedreich ataxia: The California biotech’s DT-216P2 given at 1 mg/kg led to an average 6.4-point improvement on …​ ​Read More

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version